32 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
efforts and business operations, environmental damage resulting in costly clean-up and liabilities under applicable laws and regulations governing the use
ARS
t9o940ty98w6uf gxn
28 Apr 23
Annual report to shareholders
7:03am
8-K
EX-10.1
yep2b4l6cr2qqto 2ep
30 Nov 21
Entry into a Material Definitive Agreement
4:18pm
S-3ASR
EX-1.2
2hb6b3 9x
10 Nov 21
Automatic shelf registration
5:19pm
424B4
2h7339r2srmzyow77rdq
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
ozbbg58appuohv9u5l
19 May 21
Draft registration statement
12:00am
10-K
18y6agc1flbr3j1sfh5
11 Mar 21
Annual report
4:19pm